FDA Releases Recommendations on Using the Inactive Ingredient Database

Drug GMP Report
A A
The FDA issued draft recommendations for drug developers on how to make the best use of the agency’s online database of inactive ingredients.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00